Eur Respir J
Eur Respir J
Country: Unknown
Publisher: Unknown
Publication Period: Unknown
292
Papers in Database
Journal Information
Publication Details
Additional Information
Subject Term Count: 1
Last Updated: Aug 05, 2025
Recent Papers
View All 292 PapersAssociations of combined phenotypic ageing and genetic risk with incidence of chronic respiratory diseases in the UK Bi…
Wang T, Duan W, Jia X, Huang X, Liu Y, Meng F, Ni C.
CPAP resumption after a first termination and impact on all-cause mortality in France.
Pépin JL, Tamisier R, Benjafield AV, Rinder P, Lavergne F, Josseran A, Sinel-Boucher P, Cistulli PA…
Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain.
Kerem E, Orenti A, Adamoli A, Hatziagorou E, Naehrlich L, Sermet-Gaudelus I, and the ECFS Patient R…
Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations.
Houston CJ, Alkhatib A, Einarsson GG, Tunney MM, Taggart CC, Downey DG.
Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alv…
Campo I, Carey BC, Paracchini E, Kadija Z, De Silvestri A, Rodi G, De Amici M, Torre C, Zorzetto M,…
PET-CT-guided <i>versus</i> CT-guided biopsy in suspected malignant pleural thickening: a randomised trial.
de Fonseka D, Arnold DT, Smartt HJM, Culliford L, Stadon L, Tucker E, Morley A, Zahan-Evans N, Bibb…
The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension a…
Müller J, Titz A, Schneider SR, Bauer M, Mayer L, Lüönd L, Ulrich T, Furian M, Forrer A, Schwarz EI…
Adult-onset idiopathic peripheral pulmonary artery stenosis.
Tamura Y, Tamura Y, Shigeta A, Hosokawa K, Taniguchi Y, Inami T, Adachi S, Tsujino I, Nakanishi N, …
Age-related changes in plasma biomarkers and their association with mortality in COVID-19.
Michels EHA, Appelman B, de Brabander J, van Amstel RBE, Chouchane O, van Linge CCA, Schuurman AR, …
A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases.
Addante A, Raymond W, Gitlin I, Charbit A, Orain X, Scheffler AW, Kuppe A, Duerr J, Daniltchenko M,…